1.27 USD
↗ 0.00 (0.00%)AT CLOSE (03:59 PM EST)
Enlivex Ltd. Ordinary Shares
ENLVNASDAQ • USD
1.28
↗ 0.01 (0.39%)
POST MARKET (AS OF 04:11 PM EST)
Post Market
AS OF 04:11 PM EST
1.28
↗ 0.01 (0.39%)
Market: CLOSED
ENLV is currently priced at $1.27. The technical outlook is "Sell" and the fundamental picture shows "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest ENLV is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Nov 6, 2026.
Open?$1.27
High?$1.30
Low?$1.23
Prev. Close?$1.27
Volume?18.1K
Avg. Volume?1.7M
VWAP?$1.28
Rel. Volume?0.01x
Bid / Ask
Bid?$1.18 × 300
Ask?$1.30 × 200
Spread?$0.12
Midpoint?$1.24
Valuation & Ratios
Market Cap?1.9M
Shares Out?1.5M
Float?2.2M
Float %?13.3%
P/E Ratio?N/A
P/B Ratio?0.05
EPS?-$5.50
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?23
Short Sent.?63
Piotroski F-Score?0/9Weak
Altman Z-Score?6.42Safe
Confidence?40%Low
Short InterestElevated
Short % of Float?7.09%Elevated
Short Interest?159.3K
Days to Cover?1.0
Free Float2.2M
Avg Daily Volume4.0M
Settlement Date2026-10-15
Financial Health
Current Ratio?8.72Strong
Quick Ratio?8.72Strong
Cash Ratio?1.30Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.05CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?0.4CHEAP▾
Peers100
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-23.7%WEAK▾
S&P7
ROA?-20.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$-3727368
Fundamentals ratios updated end of day